Rashid Bux: Biomark’s Early Detection of Hard to Detect and Treat Cancers Through a Liquid Biopsy Platform
BioMark is a N. American life sciences company which has developed a state-of-the-art liquid biopsy platform for the early detection of hard to detect and treat cancers such as lung, and pancreatic brain(GBM). We are developing the next generation of molecular diagnostic